APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pipeline Embolization Device (PED)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pipeline Embolization Device (PED) Market Analysis and Forecast 2026-2032

5 July 2026199 pages

Choose your research edition.

Industry ResearchPipeline Embolization Device (PED) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pipeline Embolization Device (PED) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pipeline Embolization Device (PED) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pipeline Embolization Device (PED) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pipeline Embolization Device (PED) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pipeline Embolization Device (PED) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pipeline Embolization Device (PED) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pipeline Embolization Device (PED) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pipeline Embolization Device (PED) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pipeline Embolization Device (PED) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pipeline Embolization Device (PED) include Ascendis Health, Balt Extrusion, Boston Scientific, Codman, Evasc, Microvention, Phenox GmbH, Accumedical and ZYLOX-TONBRIDGE, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pipeline Embolization Device (PED), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pipeline Embolization Device (PED), also provides the sales of main regions and countries. Of the upcoming market potential for Pipeline Embolization Device (PED), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pipeline Embolization Device (PED) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pipeline Embolization Device (PED) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pipeline Embolization Device (PED) sales, projected growth trends, production technology, application and end-user industry.

Pipeline Embolization Device (PED) Segment by Company

Ascendis Health

Balt Extrusion

Boston Scientific

Codman

Evasc

Microvention

Phenox GmbH

Accumedical

ZYLOX-TONBRIDGE

Medtronic

Johnson & Johnson

Stryker Corporation

MicroPort

Pipeline Embolization Device (PED) Segment by Type

48 Alloy Wire Braided

64 Alloy Wire Braided

Other

Pipeline Embolization Device (PED) Segment by Application

Intracranial Aneurysm Treatment

Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

Other

Pipeline Embolization Device (PED) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pipeline Embolization Device (PED) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pipeline Embolization Device (PED) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pipeline Embolization Device (PED).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pipeline Embolization Device (PED) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pipeline Embolization Device (PED) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pipeline Embolization Device (PED) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pipeline Embolization Device (PED) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 48 Alloy Wire Braided Major Manufacturers Table 3. 64 Alloy Wire Braided Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Pipeline Embolization Device (PED) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Intracranial Aneurysm Treatment Major Manufacturers Table 7. Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Major Manufacturers Table 8. Other Major Manufacturers Table 9. Pipeline Embolization Device (PED) Industry Trends Table 10. Pipeline Embolization Device (PED) Industry Drivers Table 11. Pipeline Embolization Device (PED) Industry Opportunities and Challenges Table 12. Pipeline Embolization Device (PED) Industry Restraints Table 13. Global Pipeline Embolization Device (PED) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pipeline Embolization Device (PED) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pipeline Embolization Device (PED) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2021-2026) Table 17. Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2027-2032) Table 18. Global Pipeline Embolization Device (PED) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Pipeline Embolization Device (PED) Sales by Region (2021-2026) & (k units) Table 20. Global Pipeline Embolization Device (PED) Sales by Region (2027-2032) & (k units) Table 21. Global Pipeline Embolization Device (PED) Sales Market Share by Region (2021-2026) Table 22. Global Pipeline Embolization Device (PED) Sales Market Share by Region (2027-2032) Table 23. Global Pipeline Embolization Device (PED) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pipeline Embolization Device (PED) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pipeline Embolization Device (PED) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pipeline Embolization Device (PED) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pipeline Embolization Device (PED) Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Pipeline Embolization Device (PED) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pipeline Embolization Device (PED) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pipeline Embolization Device (PED) Manufacturers, Product Type & Application Table 31. Global Pipeline Embolization Device (PED) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pipeline Embolization Device (PED) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pipeline Embolization Device (PED) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2026) Table 38. Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2027-2032) Table 39. Global Pipeline Embolization Device (PED) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 41. Global Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 42. Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2026) Table 43. Global Pipeline Embolization Device (PED) Sales Market Share by Type (2027-2032) Table 44. Global Pipeline Embolization Device (PED) Price by Type (2021-2026) & (USD/unit) Table 45. Global Pipeline Embolization Device (PED) Price by Type (2027-2032) & (USD/unit) Table 46. Global Pipeline Embolization Device (PED) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2026) Table 50. Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2027-2032) Table 51. Global Pipeline Embolization Device (PED) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 53. Global Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 54. Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2026) Table 55. Global Pipeline Embolization Device (PED) Sales Market Share by Application (2027-2032) Table 56. Global Pipeline Embolization Device (PED) Price by Application (2021-2026) & (USD/unit) Table 57. Global Pipeline Embolization Device (PED) Price by Application (2027-2032) & (USD/unit) Table 58. Ascendis Health Company Information Table 59. Ascendis Health Business Overview Table 60. Ascendis Health Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Ascendis Health Pipeline Embolization Device (PED) Product Portfolio Table 62. Ascendis Health Recent Development Table 63. Balt Extrusion Company Information Table 64. Balt Extrusion Business Overview Table 65. Balt Extrusion Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio Table 67. Balt Extrusion Recent Development Table 68. Boston Scientific Company Information Table 69. Boston Scientific Business Overview Table 70. Boston Scientific Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Boston Scientific Pipeline Embolization Device (PED) Product Portfolio Table 72. Boston Scientific Recent Development Table 73. Codman Company Information Table 74. Codman Business Overview Table 75. Codman Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Codman Pipeline Embolization Device (PED) Product Portfolio Table 77. Codman Recent Development Table 78. Evasc Company Information Table 79. Evasc Business Overview Table 80. Evasc Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Evasc Pipeline Embolization Device (PED) Product Portfolio Table 82. Evasc Recent Development Table 83. Microvention Company Information Table 84. Microvention Business Overview Table 85. Microvention Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Microvention Pipeline Embolization Device (PED) Product Portfolio Table 87. Microvention Recent Development Table 88. Phenox GmbH Company Information Table 89. Phenox GmbH Business Overview Table 90. Phenox GmbH Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio Table 92. Phenox GmbH Recent Development Table 93. Accumedical Company Information Table 94. Accumedical Business Overview Table 95. Accumedical Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Accumedical Pipeline Embolization Device (PED) Product Portfolio Table 97. Accumedical Recent Development Table 98. ZYLOX-TONBRIDGE Company Information Table 99. ZYLOX-TONBRIDGE Business Overview Table 100. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio Table 102. ZYLOX-TONBRIDGE Recent Development Table 103. Medtronic Company Information Table 104. Medtronic Business Overview Table 105. Medtronic Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Medtronic Pipeline Embolization Device (PED) Product Portfolio Table 107. Medtronic Recent Development Table 108. Johnson & Johnson Company Information Table 109. Johnson & Johnson Business Overview Table 110. Johnson & Johnson Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio Table 112. Johnson & Johnson Recent Development Table 113. Stryker Corporation Company Information Table 114. Stryker Corporation Business Overview Table 115. Stryker Corporation Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio Table 117. Stryker Corporation Recent Development Table 118. MicroPort Company Information Table 119. MicroPort Business Overview Table 120. MicroPort Pipeline Embolization Device (PED) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. MicroPort Pipeline Embolization Device (PED) Product Portfolio Table 122. MicroPort Recent Development Table 123. North America Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 126. North America Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 127. North America Pipeline Embolization Device (PED) Sales Price by Type (2021-2026) & (USD/unit) Table 128. North America Pipeline Embolization Device (PED) Sales Price by Type (2027-2032) & (USD/unit) Table 129. North America Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 132. North America Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 133. North America Pipeline Embolization Device (PED) Sales Price by Application (2021-2026) & (USD/unit) Table 134. North America Pipeline Embolization Device (PED) Sales Price by Application (2027-2032) & (USD/unit) Table 135. North America Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 139. North America Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 140. North America Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 141. North America Pipeline Embolization Device (PED) Sales Price by Country (2021-2026) & (USD/unit) Table 142. North America Pipeline Embolization Device (PED) Sales Price by Country (2027-2032) & (USD/unit) Table 143. United States Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 144. Canada Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 145. Mexico Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 146. Europe Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 149. Europe Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 150. Europe Pipeline Embolization Device (PED) Sales Price by Type (2021-2026) & (USD/unit) Table 151. Europe Pipeline Embolization Device (PED) Sales Price by Type (2027-2032) & (USD/unit) Table 152. Europe Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 155. Europe Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 156. Europe Pipeline Embolization Device (PED) Sales Price by Application (2021-2026) & (USD/unit) Table 157. Europe Pipeline Embolization Device (PED) Sales Price by Application (2027-2032) & (USD/unit) Table 158. Europe Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Europe Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 163. Europe Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 164. Europe Pipeline Embolization Device (PED) Sales Price by Country (2021-2026) & (USD/unit) Table 165. Europe Pipeline Embolization Device (PED) Sales Price by Country (2027-2032) & (USD/unit) Table 166. Germany Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 167. France Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 168. U.K. Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 169. Italy Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 170. Russia Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 171. Spain Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 174. Sweden Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 175. Poland Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 176. China Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (US$ Million) Table 177. China Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (US$ Million) Table 178. China Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 179. China Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 180. China Pipeline Embolization Device (PED) Sales Price by Type (2021-2026) & (USD/unit) Table 181. China Pipeline Embolization Device (PED) Sales Price by Type (2027-2032) & (USD/unit) Table 182. China Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (US$ Million) Table 183. China Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (US$ Million) Table 184. China Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 185. China Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 186. China Pipeline Embolization Device (PED) Sales Price by Application (2021-2026) & (USD/unit) Table 187. China Pipeline Embolization Device (PED) Sales Price by Application (2027-2032) & (USD/unit) Table 188. Asia Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 191. Asia Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 192. Asia Pipeline Embolization Device (PED) Sales Price by Type (2021-2026) & (USD/unit) Table 193. Asia Pipeline Embolization Device (PED) Sales Price by Type (2027-2032) & (USD/unit) Table 194. Asia Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 197. Asia Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 198. Asia Pipeline Embolization Device (PED) Sales Price by Application (2021-2026) & (USD/unit) Table 199. Asia Pipeline Embolization Device (PED) Sales Price by Application (2027-2032) & (USD/unit) Table 200. Asia Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 204. Asia Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 205. Asia Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 206. Asia Pipeline Embolization Device (PED) Sales Price by Country (2021-2026) & (USD/unit) Table 207. Asia Pipeline Embolization Device (PED) Sales Price by Country (2027-2032) & (USD/unit) Table 208. Japan Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 209. South Korea Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 210. India Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 211. Australia Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Pipeline Embolization Device (PED) Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Pipeline Embolization Device (PED) Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Pipeline Embolization Device (PED) Sales by Type (2021-2026) & (k units) Table 217. SAMEA Pipeline Embolization Device (PED) Sales by Type (2027-2032) & (k units) Table 218. SAMEA Pipeline Embolization Device (PED) Sales Price by Type (2021-2026) & (USD/unit) Table 219. SAMEA Pipeline Embolization Device (PED) Sales Price by Type (2027-2032) & (USD/unit) Table 220. SAMEA Pipeline Embolization Device (PED) Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Pipeline Embolization Device (PED) Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Pipeline Embolization Device (PED) Sales by Application (2021-2026) & (k units) Table 223. SAMEA Pipeline Embolization Device (PED) Sales by Application (2027-2032) & (k units) Table 224. SAMEA Pipeline Embolization Device (PED) Sales Price by Application (2021-2026) & (USD/unit) Table 225. SAMEA Pipeline Embolization Device (PED) Sales Price by Application (2027-2032) & (USD/unit) Table 226. SAMEA Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 230. SAMEA Pipeline Embolization Device (PED) Sales by Country (2021-2026) & (k units) Table 231. SAMEA Pipeline Embolization Device (PED) Sales by Country (2027-2032) & (k units) Table 232. SAMEA Pipeline Embolization Device (PED) Sales Price by Country (2021-2026) & (USD/unit) Table 233. SAMEA Pipeline Embolization Device (PED) Sales Price by Country (2027-2032) & (USD/unit) Table 234. Brazil Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 235. Argentina Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 236. Chile Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 237. Colombia Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 238. Peru Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 240. Israel Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 241. UAE Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 242. Turkey Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 243. Iran Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 244. Egypt Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Pipeline Embolization Device (PED) Distributors List Table 248. Pipeline Embolization Device (PED) Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Pipeline Embolization Device (PED) Image Figure 2. Global Pipeline Embolization Device (PED) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pipeline Embolization Device (PED) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 48 Alloy Wire Braided Image Figure 5. 64 Alloy Wire Braided Image Figure 6. Other Image Figure 7. Global Pipeline Embolization Device (PED) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pipeline Embolization Device (PED) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Intracranial Aneurysm Treatment Image Figure 10. Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.) Image Figure 11. Other Image Figure 12. Global Pipeline Embolization Device (PED) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pipeline Embolization Device (PED) Revenue (2021-2032) & (US$ Million) Figure 14. Global Pipeline Embolization Device (PED) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pipeline Embolization Device (PED) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2021-2032) Figure 17. Global Pipeline Embolization Device (PED) Sales (2021-2032) & (k units) Figure 18. Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Pipeline Embolization Device (PED) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pipeline Embolization Device (PED) Sales YoY (2021-2032) & (k units) Figure 21. Europe Pipeline Embolization Device (PED) Sales YoY (2021-2032) & (k units) Figure 22. China Pipeline Embolization Device (PED) Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Pipeline Embolization Device (PED) Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Pipeline Embolization Device (PED) Sales YoY (2021-2032) & (k units) Figure 25. Global Pipeline Embolization Device (PED) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pipeline Embolization Device (PED) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pipeline Embolization Device (PED) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pipeline Embolization Device (PED) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2032) Figure 31. Global Pipeline Embolization Device (PED) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Pipeline Embolization Device (PED) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2032) Figure 34. Global Pipeline Embolization Device (PED) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pipeline Embolization Device (PED) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2032) Figure 37. Global Pipeline Embolization Device (PED) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Pipeline Embolization Device (PED) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2032) Figure 40. North America Pipeline Embolization Device (PED) Revenue Share by Type (2021-2032) Figure 41. North America Pipeline Embolization Device (PED) Sales Share by Type (2021-2032) Figure 42. North America Pipeline Embolization Device (PED) Revenue Share by Application (2021-2032) Figure 43. North America Pipeline Embolization Device (PED) Sales Share by Application (2021-2032) Figure 44. North America Pipeline Embolization Device (PED) Revenue Share by Country (2021-2032) Figure 45. North America Pipeline Embolization Device (PED) Sales Share by Country (2021-2032) Figure 46. Europe Pipeline Embolization Device (PED) Revenue Share by Type (2021-2032) Figure 47. Europe Pipeline Embolization Device (PED) Sales Share by Type (2021-2032) Figure 48. Europe Pipeline Embolization Device (PED) Revenue Share by Application (2021-2032) Figure 49. Europe Pipeline Embolization Device (PED) Sales Share by Application (2021-2032) Figure 50. Europe Pipeline Embolization Device (PED) Revenue Share by Country (2021-2032) Figure 51. Europe Pipeline Embolization Device (PED) Sales Share by Country (2021-2032) Figure 52. China Pipeline Embolization Device (PED) Revenue Share by Type (2021-2032) Figure 53. China Pipeline Embolization Device (PED) Sales Share by Type (2021-2032) Figure 54. China Pipeline Embolization Device (PED) Revenue Share by Application (2021-2032) Figure 55. China Pipeline Embolization Device (PED) Sales Share by Application (2021-2032) Figure 56. Asia Pipeline Embolization Device (PED) Revenue Share by Type (2021-2032) Figure 57. Asia Pipeline Embolization Device (PED) Sales Share by Type (2021-2032) Figure 58. Asia Pipeline Embolization Device (PED) Revenue Share by Application (2021-2032) Figure 59. Asia Pipeline Embolization Device (PED) Sales Share by Application (2021-2032) Figure 60. Asia Pipeline Embolization Device (PED) Revenue Share by Country (2021-2032) Figure 61. Asia Pipeline Embolization Device (PED) Sales Share by Country (2021-2032) Figure 62. SAMEA Pipeline Embolization Device (PED) Revenue Share by Type (2021-2032) Figure 63. SAMEA Pipeline Embolization Device (PED) Sales Share by Type (2021-2032) Figure 64. SAMEA Pipeline Embolization Device (PED) Revenue Share by Application (2021-2032) Figure 65. SAMEA Pipeline Embolization Device (PED) Sales Share by Application (2021-2032) Figure 66. SAMEA Pipeline Embolization Device (PED) Revenue Share by Country (2021-2032) Figure 67. SAMEA Pipeline Embolization Device (PED) Sales Share by Country (2021-2032) Figure 68. Pipeline Embolization Device (PED) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pipeline Embolization Device (PED) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 48 Alloy Wire Braided
  • 64 Alloy Wire Braided
  • Other
Applications
  • Intracranial Aneurysm Treatment
  • Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  • Other
Companies covered
  • Ascendis Health
  • Balt Extrusion
  • Boston Scientific
  • Codman
  • Evasc
  • Microvention
  • Phenox GmbH
  • Accumedical
  • ZYLOX-TONBRIDGE
  • Medtronic
  • Johnson & Johnson
  • Stryker Corporation
  • MicroPort

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pipeline Embolization Device (PED) Market by Type
  3. 1.2.1 Global Pipeline Embolization Device (PED) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 48 Alloy Wire Braided
  5. 1.2.3 64 Alloy Wire Braided
  6. 1.2.4 Other
  7. 1.3 Pipeline Embolization Device (PED) Market by Application
  8. 1.3.1 Global Pipeline Embolization Device (PED) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Intracranial Aneurysm Treatment
  10. 1.3.3 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pipeline Embolization Device (PED) Market Dynamics
  1. 2.1 Pipeline Embolization Device (PED) Industry Trends
  2. 2.2 Pipeline Embolization Device (PED) Industry Drivers
  3. 2.3 Pipeline Embolization Device (PED) Industry Opportunities and Challenges
  4. 2.4 Pipeline Embolization Device (PED) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pipeline Embolization Device (PED) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pipeline Embolization Device (PED) Revenue by Region
  3. 3.2.1 Global Pipeline Embolization Device (PED) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pipeline Embolization Device (PED) Revenue by Region (2021-2026)
  5. 3.2.3 Global Pipeline Embolization Device (PED) Revenue by Region (2027-2032)
  6. 3.2.4 Global Pipeline Embolization Device (PED) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pipeline Embolization Device (PED) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pipeline Embolization Device (PED) Sales by Region
  9. 3.4.1 Global Pipeline Embolization Device (PED) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pipeline Embolization Device (PED) Sales by Region (2021-2026)
  11. 3.4.3 Global Pipeline Embolization Device (PED) Sales by Region (2027-2032)
  12. 3.4.4 Global Pipeline Embolization Device (PED) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pipeline Embolization Device (PED) Revenue by Manufacturers
  2. 4.1.1 Global Pipeline Embolization Device (PED) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pipeline Embolization Device (PED) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pipeline Embolization Device (PED) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pipeline Embolization Device (PED) Sales by Manufacturers
  6. 4.2.1 Global Pipeline Embolization Device (PED) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pipeline Embolization Device (PED) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pipeline Embolization Device (PED) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pipeline Embolization Device (PED) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pipeline Embolization Device (PED) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pipeline Embolization Device (PED) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pipeline Embolization Device (PED) Manufacturers, Product Type & Application
  13. 4.7 Global Pipeline Embolization Device (PED) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pipeline Embolization Device (PED) Market CR5 and HHI
  16. 4.8.2 2025 Pipeline Embolization Device (PED) Tier 1, Tier 2, and Tier 3
5 Pipeline Embolization Device (PED) Market by Type
  1. 5.1 Global Pipeline Embolization Device (PED) Revenue by Type
  2. 5.1.1 Global Pipeline Embolization Device (PED) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pipeline Embolization Device (PED) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pipeline Embolization Device (PED) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pipeline Embolization Device (PED) Sales by Type
  6. 5.2.1 Global Pipeline Embolization Device (PED) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pipeline Embolization Device (PED) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pipeline Embolization Device (PED) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pipeline Embolization Device (PED) Price by Type
6 Pipeline Embolization Device (PED) Market by Application
  1. 6.1 Global Pipeline Embolization Device (PED) Revenue by Application
  2. 6.1.1 Global Pipeline Embolization Device (PED) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pipeline Embolization Device (PED) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pipeline Embolization Device (PED) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pipeline Embolization Device (PED) Sales by Application
  6. 6.2.1 Global Pipeline Embolization Device (PED) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pipeline Embolization Device (PED) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pipeline Embolization Device (PED) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pipeline Embolization Device (PED) Price by Application
7 Company Profiles
  1. 7.1 Ascendis Health
  2. 7.1.1 Ascendis Health Company Information
  3. 7.1.2 Ascendis Health Business Overview
  4. 7.1.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ascendis Health Pipeline Embolization Device (PED) Product Portfolio
  6. 7.1.5 Ascendis Health Recent Developments
  7. 7.2 Balt Extrusion
  8. 7.2.1 Balt Extrusion Company Information
  9. 7.2.2 Balt Extrusion Business Overview
  10. 7.2.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolio
  12. 7.2.5 Balt Extrusion Recent Developments
  13. 7.3 Boston Scientific
  14. 7.3.1 Boston Scientific Company Information
  15. 7.3.2 Boston Scientific Business Overview
  16. 7.3.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boston Scientific Pipeline Embolization Device (PED) Product Portfolio
  18. 7.3.5 Boston Scientific Recent Developments
  19. 7.4 Codman
  20. 7.4.1 Codman Company Information
  21. 7.4.2 Codman Business Overview
  22. 7.4.3 Codman Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Codman Pipeline Embolization Device (PED) Product Portfolio
  24. 7.4.5 Codman Recent Developments
  25. 7.5 Evasc
  26. 7.5.1 Evasc Company Information
  27. 7.5.2 Evasc Business Overview
  28. 7.5.3 Evasc Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Evasc Pipeline Embolization Device (PED) Product Portfolio
  30. 7.5.5 Evasc Recent Developments
  31. 7.6 Microvention
  32. 7.6.1 Microvention Company Information
  33. 7.6.2 Microvention Business Overview
  34. 7.6.3 Microvention Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Microvention Pipeline Embolization Device (PED) Product Portfolio
  36. 7.6.5 Microvention Recent Developments
  37. 7.7 Phenox GmbH
  38. 7.7.1 Phenox GmbH Company Information
  39. 7.7.2 Phenox GmbH Business Overview
  40. 7.7.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolio
  42. 7.7.5 Phenox GmbH Recent Developments
  43. 7.8 Accumedical
  44. 7.8.1 Accumedical Company Information
  45. 7.8.2 Accumedical Business Overview
  46. 7.8.3 Accumedical Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Accumedical Pipeline Embolization Device (PED) Product Portfolio
  48. 7.8.5 Accumedical Recent Developments
  49. 7.9 ZYLOX-TONBRIDGE
  50. 7.9.1 ZYLOX-TONBRIDGE Company Information
  51. 7.9.2 ZYLOX-TONBRIDGE Business Overview
  52. 7.9.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolio
  54. 7.9.5 ZYLOX-TONBRIDGE Recent Developments
  55. 7.10 Medtronic
  56. 7.10.1 Medtronic Company Information
  57. 7.10.2 Medtronic Business Overview
  58. 7.10.3 Medtronic Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Medtronic Pipeline Embolization Device (PED) Product Portfolio
  60. 7.10.5 Medtronic Recent Developments
  61. 7.11 Johnson & Johnson
  62. 7.11.1 Johnson & Johnson Company Information
  63. 7.11.2 Johnson & Johnson Business Overview
  64. 7.11.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolio
  66. 7.11.5 Johnson & Johnson Recent Developments
  67. 7.12 Stryker Corporation
  68. 7.12.1 Stryker Corporation Company Information
  69. 7.12.2 Stryker Corporation Business Overview
  70. 7.12.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolio
  72. 7.12.5 Stryker Corporation Recent Developments
  73. 7.13 MicroPort
  74. 7.13.1 MicroPort Company Information
  75. 7.13.2 MicroPort Business Overview
  76. 7.13.3 MicroPort Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 MicroPort Pipeline Embolization Device (PED) Product Portfolio
  78. 7.13.5 MicroPort Recent Developments
8 North America
  1. 8.1 North America Pipeline Embolization Device (PED) Market Size by Type
  2. 8.1.1 North America Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
  3. 8.1.2 North America Pipeline Embolization Device (PED) Sales by Type (2021-2032)
  4. 8.1.3 North America Pipeline Embolization Device (PED) Price by Type (2021-2032)
  5. 8.2 North America Pipeline Embolization Device (PED) Market Size by Application
  6. 8.2.1 North America Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
  7. 8.2.2 North America Pipeline Embolization Device (PED) Sales by Application (2021-2032)
  8. 8.2.3 North America Pipeline Embolization Device (PED) Price by Application (2021-2032)
  9. 8.3 North America Pipeline Embolization Device (PED) Market Size by Country
  10. 8.3.1 North America Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pipeline Embolization Device (PED) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pipeline Embolization Device (PED) Market Size by Type
  2. 9.1.1 Europe Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pipeline Embolization Device (PED) Sales by Type (2021-2032)
  4. 9.1.3 Europe Pipeline Embolization Device (PED) Price by Type (2021-2032)
  5. 9.2 Europe Pipeline Embolization Device (PED) Market Size by Application
  6. 9.2.1 Europe Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pipeline Embolization Device (PED) Sales by Application (2021-2032)
  8. 9.2.3 Europe Pipeline Embolization Device (PED) Price by Application (2021-2032)
  9. 9.3 Europe Pipeline Embolization Device (PED) Market Size by Country
  10. 9.3.1 Europe Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pipeline Embolization Device (PED) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pipeline Embolization Device (PED) Market Size by Type
  2. 10.1.1 China Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
  3. 10.1.2 China Pipeline Embolization Device (PED) Sales by Type (2021-2032)
  4. 10.1.3 China Pipeline Embolization Device (PED) Price by Type (2021-2032)
  5. 10.2 China Pipeline Embolization Device (PED) Market Size by Application
  6. 10.2.1 China Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
  7. 10.2.2 China Pipeline Embolization Device (PED) Sales by Application (2021-2032)
  8. 10.2.3 China Pipeline Embolization Device (PED) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pipeline Embolization Device (PED) Market Size by Type
  2. 11.1.1 Asia Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pipeline Embolization Device (PED) Sales by Type (2021-2032)
  4. 11.1.3 Asia Pipeline Embolization Device (PED) Price by Type (2021-2032)
  5. 11.2 Asia Pipeline Embolization Device (PED) Market Size by Application
  6. 11.2.1 Asia Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pipeline Embolization Device (PED) Sales by Application (2021-2032)
  8. 11.2.3 Asia Pipeline Embolization Device (PED) Price by Application (2021-2032)
  9. 11.3 Asia Pipeline Embolization Device (PED) Market Size by Country
  10. 11.3.1 Asia Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pipeline Embolization Device (PED) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pipeline Embolization Device (PED) Market Size by Type
  2. 12.1.1 SAMEA Pipeline Embolization Device (PED) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pipeline Embolization Device (PED) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pipeline Embolization Device (PED) Price by Type (2021-2032)
  5. 12.2 SAMEA Pipeline Embolization Device (PED) Market Size by Application
  6. 12.2.1 SAMEA Pipeline Embolization Device (PED) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pipeline Embolization Device (PED) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pipeline Embolization Device (PED) Price by Application (2021-2032)
  9. 12.3 SAMEA Pipeline Embolization Device (PED) Market Size by Country
  10. 12.3.1 SAMEA Pipeline Embolization Device (PED) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pipeline Embolization Device (PED) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pipeline Embolization Device (PED) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pipeline Embolization Device (PED) Value Chain Analysis
  2. 13.1.1 Pipeline Embolization Device (PED) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pipeline Embolization Device (PED) Production Mode & Process
  6. 13.2 Pipeline Embolization Device (PED) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pipeline Embolization Device (PED) Distributors
  9. 13.2.3 Pipeline Embolization Device (PED) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst